Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Bionxt Solutions Inc. (BNXT.CN)

Bionxt Solutions Inc. (BNXT.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BioNxt Reports “Intention to Grant” Patent Notification from the European Patent Office for Its Oral Cladribine Sublingual Thin-Film as the Multiple Sclerosis Market Shifts Toward Patient-Friendly Therapies PressReach - Tue Nov 4, 2025

VANCOUVER, BC / November 4, 2025 / BioNxt Solutions Inc. (“BioNxt” or the “Company”) (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to announce that its wholly owned German subsidiary, Vektor Pharma...

BNXT.CN : 0.6000 (-1.64%)
BNXTF : 0.4553 (-5.13%)
BioNxt Reports “Readiness to Grant” Patent Notification from the Eurasian Patent Organization PressReach - Thu Oct 30, 2025

VANCOUVER, BC / October 30, 2025 / BioNxt Solutions Inc. (“BioNxt” or the “Company”) (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is...

BNXT.CN : 0.6000 (-1.64%)
BNXTF : 0.4553 (-5.13%)
BioNxt Enters the Final Stretch Before Human Trials for Next-Generation MS Drug PressReach - Wed Oct 22, 2025

BioNxt Solutions Inc. (CSE:BNXT) (OTCQB:BNXTF) (FSE:BXT), a bioscience company developing next-generation drug delivery technologies, has launched a 15-day dosing optimization study for its lead product...

BNXT.CN : 0.6000 (-1.64%)
BNXTF : 0.4553 (-5.13%)
BioNxt Launches 15-day Sublingual Cladribine Dosing Optimization Study in Preparation for Human Bioequivalence Study PressReach - Tue Oct 21, 2025

VANCOUVER, BC / October 21, 2025 / BioNxt Solutions Inc. (“BioNxt” or the “Company”) (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in next-generation drug delivery technologies,...

BNXT.CN : 0.6000 (-1.64%)
BNXTF : 0.4553 (-5.13%)
BioNxt Solutions Announces Delay In Filing 2024 Annual Financial Statements ACCESS Newswire - Thu May 1, 2025

VANCOUVER, BC / ACCESS Newswire / May 1, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT), announces that its annual financial statements for the year ended December...

BNXT.CN : 0.6000 (-1.64%)
BNXTF : 0.4553 (-5.13%)
BioNxt Solutions Prepares for Human Bioequivalence Study For MS ACCESS Newswire - Tue Apr 22, 2025

VANCOUVER, BC / ACCESS Newswire / April 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems,...

BNXT.CN : 0.6000 (-1.64%)
BNXTF : 0.4553 (-5.13%)
BioNxt Solutions Announces Closing of Final Tranche of Fully Subscribed Convertible Debenture Unit Private Placement ACCESS Newswire - Fri Mar 14, 2025

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

BNXT.CN : 0.6000 (-1.64%)
BNXTF : 0.4553 (-5.13%)
BioNxt Solutions Announces Closing of First Tranche of Convertible Debenture Unit Private Placement ACCESS Newswire - Fri Feb 28, 2025

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

BNXT.CN : 0.6000 (-1.64%)
BNXTF : 0.4553 (-5.13%)
BioNxt Solutions Announces Debenture Unit Financing ACCESS Newswire - Mon Feb 24, 2025

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

BNXT.CN : 0.6000 (-1.64%)
BNXTF : 0.4553 (-5.13%)
Clarification of Promotional Activities ACCESS Newswire - Fri Feb 21, 2025

VANCOUVER, BC / ACCESS Newswire / February 21, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:4XT) reports a clarification to its news release dated January 31,...

BNXT.CN : 0.6000 (-1.64%)
BNXTF : 0.4553 (-5.13%)

Barchart Exclusives

Stock Index Futures Gain on Iran Outreach Report, U.S. ADP Jobs Data Awaited Barchart - 16 minutes ago
March S&P 500 E-Mini futures (ESH26) are up +0.23%, and March Nasdaq 100 E-Mini futures (NQH26) are up +0.28% this morning as sentiment improved slightly following a report that Iran had made indirect contact with the U.S. to negotiate an end to the Middle East conflict. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot